Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-03-29
1996-01-16
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 17, 514 19, 530331, 562561, 562571, A61K 3806
Patent
active
054847710
ABSTRACT:
Described herein are peptide derivatives of the formula R.sup.1 NH--CO--Q--C(O)--NR.sup.2 --CH[CH.sub.2 C(O)--Y]--C(O)--NH--CH[CR.sup.3 (R.sup.4)--COOH]--C(W)--NH--CHR.sup.5 --Z wherein R.sup.1 is an optionally substituted alkyl or optionally substituted phenylalkyl, R.sup.2 is hydrogen or alkyl, R.sup.3 and R.sup.4 each independently is hydrogen or alkyl, or R.sup.3 and R.sup.4 are joined to form a cycloalkyl. R.sup.5 is alkyl, cycloalkyl or (cycloalkyl)alkyl, Q is a divalent radical, for example, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH-- or 1,2-cyclohexanediyl, which serves as a two carbon spacer. W is oxo or thioxo, Y is, for example, an alkoxy or a monosubstituted or disubsdtuted ammo, and Z is a terminal unit, for example, hydrogen, COOH or CH.sub.2 OH. The derivatives are useful for treating herpes infections.
REFERENCES:
Gaudreau J Biol Chem 262, 12413, 1987.
Beaulieu Pierre L.
Deziel Robert
Moss Neil
Bio-Mega Boehringer Ingelheim Research Inc.
Devlin M-E. M.
Lukton David
Raymond R. P.
Stempel A. R.
LandOfFree
Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-309380